By Dan Hurley May 5, 2022 The Science Explained Article In Brief
Researchers tracked the link between cardiovascular disease (CVD) and dementia for approximately 25 years, finding that individuals whose CVD risk factors increase sharply over a period of years and decades are more than three times more likely to develop Alzheimer's disease or vascular dementia than are people whose CVD risk remains relatively steady. Our experts said the results demonstrate the need to pay greater attention to patients' CVD risk factors.
Individuals whose cardiovascular disease (CVD) risk factors increase substantially over a period of years and decades are more than three times more likely to develop Alzheimer's disease or vascular dementia than are people whose CVD risk remains relatively steady.
While previous studies have documented a link between CVD and dementia, the new study, published in Neurology online on April 20 is one of the first to prospectively trace the trajectory of the two disease states across 20 to 25 years.
The longitudinal, cumulative trajectory of cardiovascular risk is predictive of dementia risk and associated with the emergency of memory decline, the study concluded.
The findings were based on an analysis of data from the Betula study, a prospective, longitudinal, multicohort study of aging, memory, and data collected between 1988 and 2014 from 1,244 individuals based in the city of Ume, Sweden. The community-dwelling participants were healthy at baseline.
Investigators from Ume University used the Framingham Risk Score to measure cardiovascular risk in the participants every five years. They found that the risk score changed only minimally in 22 percent of participants, increased moderately in 60 percent, and increased at an accelerated pace in 18 percent.
Compared with participants with a stable risk trajectory, those with an accelerated trajectory had a 3.3 to 5.7-fold higher risk of developing Alzheimer's disease (AD) over the course of the study (95 percent confidence interval: 1.9 to 6.7 times increased risk after 25 years).
The participants whose CVD risk increased at an accelerated pace also had 3.3 to 4.1 times greater risk of developing vascular dementia (VaD; 95 percent CI: 1.5 to 7.6), and a slightly increased risk of memory decline (95 percent CI: 1.0 to 1.5).
The benefit of a stable cardiovascular risk trajectory, on the other hand, appeared to partially mitigate the risk of Alzheimer's disease for APOE4 carriers.
It has been shown that the stand-alone measurements of cardiovascular risk are predictive of later dementia, yet there are very few studies that have, or are even able, to examine the trajectory of that risk, said the first author of the paper, Bryn Farnsworth von Cederwald, PhD, a postdoctoral fellow in Ume University's department of integrative medical biology.
We wanted to find out if alternate trajectories, starting from similar risk levels, could lead to different outcomes, he told Neurology Today.
Physicians who were not involved with the study said the results demonstrate the need for neurologists to pay greater attention to their patients' CVD risk factors.
If a patient with Parkinson's disease also happens to smoke and have high blood pressure, as neurologists we tend to focus on the Parkinson's and not the cardiovascular risk, said Michelle C. Johansen, MD, assistant professor of neurology and attending physician in the cerebrovascular division at the Johns Hopkins Hospital. I am hoping that this and other recent studies will alert neurologists to pay more attention to these risk factors, which are among the few that patients and physicians can modify to avoid dementia.
Prior to the paper by Dr. Farnsworth von Cederwald, only a handful of previous studies have examined CVD risk longitudinally in relation to cognitive decline and dementia. In 2021, a paper by Hakala et al in Circulation followed a population-based cohort of 3,596 children who were aged 3 to 18 years old at the beginning of the study for 31 years. They found that elevated systolic blood pressure, high serum total cholesterol, and obesity that worsened from childhood to midlife were inversely associated with midlife cognitive performance.
Another paper, by Wagner et al in JAMA Psychiatry, described a case-control study in which adults at least 65 years old received six home visits during the 15 years between 1999 and 2014. During that time, 785 participants developed dementia, while 3,140 did not. They found that rising blood-glucose levels over the 15-year span increased the risk for developing dementia, as did falling blood pressure and body-mass index.
Yet no previous study had used such a well-validated, multi-variable measure of CVD risk as the Framingham Risk Score. Dr. Farnsworth von Cederwald and colleagues used the office-based version of the score, which measures age, gender, systolic blood pressure, blood-pressure medication usage, BMI, smoking status, and diabetes diagnosis. The aggregated score represents the likelihood of any CVD event within 10 years.
Diagnosis of AD and VaD were clinically determined and based on the DSM-IV criteria. To increase diagnostic precision, a physician also checked computerized medical records without knowledge of the clinical diagnosis.
The classification of average, stable or accelerated CVD risk trajectories were calculated in relation to participants' age and baseline risk. Given that CVD risk tends to increase with age, the average group did have a steady increase in their Framingham score. Accelerated CVD risk was defined as a rate of change one standard deviation above the mean, while stable risk was defined as a standard deviation below the mean.
Those who maintained a stable cardiovascular risk profile had a reduced risk of developing dementia compared to those who had an average or accelerated profile, Dr. Farnsworth von Cederwald said.
The finding that APOE4 carriers did not have an increased risk of AD if they maintained a stable CVD profile was particularly noteworthy, he said. This is potentially a sign that maintaining a stable CVD risk could mitigate the increased genetic risk associated with APOE4, he said.
The principal investigator of the Framingham Heart Study said that the new study offered support for an association long known in epidemiology: the so-called horse racing effect.
The faster a horse is gaining speed, the likelier it is to reach the finish line first, said Vasan Ramachandran, MD, FACC, FAHA, the Jay and Louise Coffman Professor in Vascular Dementia and chief of the section of preventive medicine at Boston University Schools of Medicine and Public Health. In this case, the finish line is the development of dementia. So, the faster a person's CVD risk profile is increasing, the more likely they are to develop memory loss, Alzheimer's disease, or vascular dementia.
Because modifying CVD risk factors are currently among the only ways to reduce the risk of dementia, Dr. Ramachandran said he hopes that neurologists will take note of those risk factors in all their patients, no matter their primary presenting signs, symptoms, or diagnosis.
You can ask them if they smoke, and if they are complying with their medicines for blood pressure, blood sugar, and cholesterol, Dr. Ramachandran said. Referring them when indicated to an endocrinologist or a cardiologist might be the best way you can care for their cognitive functions.
Dr. Johansen said the study demonstrates the need for patients with CVD risk factors to get them under control as early as possible.
Michelle M. Mielke, PhD, the chair of the department of epidemiology and prevention at Wake Forest School of Medicine, noted that a paper published earlier this year in Neurology reported that women with vascular conditions had greater cognitive decline than men with the conditions.
Although the Framingham Risk Score is stratified by sex, future research should examine whether there are sex differences in the trajectories of the FRS and dementia risk, said Dr. Mielke, who is also professor of international medicine in the section on gerontology and geriatric medicine.
Walter A. Kukull, PhD, an epidemiologist specializing in the study of Alzheimer's risk, said, The paper is a step in the right direction toward distinguishing whether cardiovascular disease progression works synergistically, antagonistically, or independently from neurocognitive disease.
In that regard, the study's reliance on DSM-IV is a little unfortunate, since it attempts to separate AD as a symptom-based diagnosis from multi-infarct dementia in an exclusionary wayeven though the authors recognize that the pathological features very frequently occur together, said Dr. Kukull, professor of epidemiology at the University of Washington in Seattle, and director of the National Alzheimer's Coordinating Center.
In February, Dr. Johansen presented the results of a study at the International Stroke Conference showing no significant decline in any measure of cognition soon after a heart attack, but a significant decline in memory, executive functioning, and global cognition during the course of several years following.
We need to realize that what's going on in the heart and brain are related, she said in a statement announcing her study's results. Managing risk factors to prevent a heart attack is actually good for your brain as well.
In an interview with Neurology Today, Dr. Johansen applauded Dr. Farnsworth von Cederwald's group for using the Framingham risk score and a prospective design that followed participants for 20 to 25 years.
That's a nice long period of follow-up, Dr. Johansen said. And they had a large cohort of over a thousand participants.
Visit link:
Worsening Cardiovascular Risk Profile Linked to Cognitive... : Neurology Today - LWW Journals
- Vascular Cell and Molecular Biology | Center for Vascular Biology | Weill Cornell ... - April 13th, 2018 [April 13th, 2018]
- APVBO-Asia Pacific Vascular Biology Organization Conference - April 18th, 2018 [April 18th, 2018]
- Vascular Biology Conferences | Vascular Surgery ... - May 5th, 2018 [May 5th, 2018]
- Vascular Discovery: From Genes to Medicine - May 7th, 2018 [May 7th, 2018]
- 2019 Vascular Cell Biology Conference GRC - May 26th, 2018 [May 26th, 2018]
- Biology 211: Taxonomy of Flowering Plants - June 7th, 2018 [June 7th, 2018]
- esm-evbo2019.org - Menu - July 27th, 2018 [July 27th, 2018]
- Vascular Biology | Pulmonary, Allergy, Sleep & Critical ... - November 16th, 2018 [November 16th, 2018]
- Lower vascular plant | biology | Britannica.com - November 18th, 2018 [November 18th, 2018]
- Vascular Biology - NAVBO - November 20th, 2018 [November 20th, 2018]
- 2019 Cerebral Vascular Biology Conference - cvent.com - November 21st, 2018 [November 21st, 2018]
- PPARs and Their Emerging Role in Vascular Biology ... - November 26th, 2018 [November 26th, 2018]
- Vascular Biology Chicago Medicine - November 30th, 2018 [November 30th, 2018]
- Vascular Biology | Society for Vascular Surgery - November 30th, 2018 [November 30th, 2018]
- Vascular Biology 2018 - NAVBO - December 19th, 2018 [December 19th, 2018]
- Vascular Biology 2019 - NAVBO - December 20th, 2018 [December 20th, 2018]
- Vascular Biology - January 22nd, 2019 [January 22nd, 2019]
- pvb2019.org Plant Vascular Biology Conference 2019 - January 31st, 2019 [January 31st, 2019]
- Plant Physiology | Basic Biology - March 12th, 2019 [March 12th, 2019]
- Awards - esm-evbo2019.org - April 23rd, 2019 [April 23rd, 2019]
- Medication and Exercise to Prevent Muscle Loss - Next Avenue - September 24th, 2019 [September 24th, 2019]
- A Snail as Fast as a Bullet, and Other Darwin-Defying Marvels - Discovery Institute - September 24th, 2019 [September 24th, 2019]
- Nature up close: Life in the Humboldt Penguin National Reserve - CBS News - September 24th, 2019 [September 24th, 2019]
- Oklahoma new hires and promotions announced - Oklahoman.com - September 24th, 2019 [September 24th, 2019]
- Quinn Capers IV, MD - TCTMD - September 24th, 2019 [September 24th, 2019]
- Cardiovascular Repair And Reconstruction Devices Market Global Industry Insights by Top Vendors, Growth, Revenue and Forecast Outlook 2019-2025 -... - September 26th, 2019 [September 26th, 2019]
- Four health projects at Boston Childrens Hospital that could help adults - The Boston Globe - September 30th, 2019 [September 30th, 2019]
- Research Officer/ Postdoctoral Researcher - The Conversation AU - October 16th, 2019 [October 16th, 2019]
- UNSW skin cancer researcher Levon Khachigian hit with string of retractions - ABC News - October 16th, 2019 [October 16th, 2019]
- Michal Wszola: We Expect to Transplant the Bioprinted Bionic Pancreas in Three to Five Years - 3DPrint.com - October 24th, 2019 [October 24th, 2019]
- 'The Blob': This mysterious 'smart' slime can solve puzzles and make decisions - CNBC - October 24th, 2019 [October 24th, 2019]
- University of Maryland and DOD collaborate to study Tick-borne Infections using 3-D models of human blood vessels - Outbreak News Today - November 19th, 2019 [November 19th, 2019]
- Submerged Vegetation Mirrors Coast's Health - Coastal Review Online - November 19th, 2019 [November 19th, 2019]
- Another health warning for e-cigarette users that has nothing to do with lung disease - MarketWatch - November 19th, 2019 [November 19th, 2019]
- E-Cigarettes Take a Dangerous Toll on Heart Health - DocWire News - November 19th, 2019 [November 19th, 2019]
- Vascular biology Department of Surgery College of ... - November 19th, 2019 [November 19th, 2019]
- US Nobel laureates tell us what they think about cancer research, moonshots, the dark side, funding, meritocracy, herd mentality, Trump, and joy - The... - November 21st, 2019 [November 21st, 2019]
- Growing Organs in the Lab: One Step Closer to Reality - BioSpace - November 21st, 2019 [November 21st, 2019]
- Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock - Business Wire - November 21st, 2019 [November 21st, 2019]
- Another Study Suggests E-cigarettes Hurt Heart Health More Than Regular Cigarettes - Science Times - November 21st, 2019 [November 21st, 2019]
- Cleveland Clinic awarded $12 million by NIH to study the link between gut microbes and heart disease - Crain's Cleveland Business - November 21st, 2019 [November 21st, 2019]
- JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD) - Yahoo Finance - November 27th, 2019 [November 27th, 2019]
- Germ-free lungs of newborn mice are partially protected against hyperoxia - The Mix - November 27th, 2019 [November 27th, 2019]
- Bethesda Health Physician Group Welcomes Fellowship-Trained Endocrine Surgeon Jessica L. Buicko, MD, to Its Team - The Boca Raton Tribune - November 27th, 2019 [November 27th, 2019]
- 9 Harvard researchers named AAAS Fellows Harvard - Harvard Gazette - November 27th, 2019 [November 27th, 2019]
- Top Technical Advances of 2019 - The Scientist - December 29th, 2019 [December 29th, 2019]
- Growing up Tyrannosaurus rex: Osteohistology refutes the pygmy Nanotyrannus and supports ontogenetic niche partitioning in juvenile Tyrannosaurus -... - January 2nd, 2020 [January 2nd, 2020]
- UCC currently taking applicants for 21 jobs with some incredible pay - Cork Beo - January 2nd, 2020 [January 2nd, 2020]
- Vascular Biology | Surgery Research | Michigan Medicine ... - January 2nd, 2020 [January 2nd, 2020]
- Sandy Bottom wetlands to receive protection for 'national ecological significance' - Citizen Times - January 14th, 2020 [January 14th, 2020]
- Why biotech is a boon for patients and investors - Spear's WMS - January 14th, 2020 [January 14th, 2020]
- Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related... - January 14th, 2020 [January 14th, 2020]
- G-protein Coupled Receptor Market Competitive Research And Precise Outlook 2019 To 2025 Dagoretti News - Dagoretti News - January 18th, 2020 [January 18th, 2020]
- Scientists revealed the oldest known scorpion on Earth - Tech Explorist - January 18th, 2020 [January 18th, 2020]
- How biology creates networks that are cheap, robust, and efficient - Penn: Office of University Communications - January 18th, 2020 [January 18th, 2020]
- Genome editing heralds new era of disease research, therapy - The Augusta Chronicle - January 18th, 2020 [January 18th, 2020]
- Research Fellow in Vascular Stem Cell Biology job with QUEENS UNIVERSITY BELFAST | 195527 - Times Higher Education (THE) - February 10th, 2020 [February 10th, 2020]
- More than skin deep: the latest innovation in 3D printing - Med-Tech Innovation - February 10th, 2020 [February 10th, 2020]
- Examining the link between menopause and heart disease risk - Medical News Bulletin - February 10th, 2020 [February 10th, 2020]
- Women Face an Increased Risk of Heart Disease With AgeRunning Can Help - runnersworld.com - February 12th, 2020 [February 12th, 2020]
- G-protein Coupled Receptor Market Competitive Research And Precise Outlook 2019 To 2025 - Galus Australis - February 15th, 2020 [February 15th, 2020]
- Valentine's Day Matters of the Heart, Biopharma-Style - BioSpace - February 15th, 2020 [February 15th, 2020]
- The Addicted Gardener: Environmental tidbits from around the world - Wicked Local Sharon - February 22nd, 2020 [February 22nd, 2020]
- UI at 150 & Beyond: 'The Quad was the best no matter what the weather' - Champaign/Urbana News-Gazette - February 22nd, 2020 [February 22nd, 2020]
- The Addicted Gardener: Environmental tidbits from around the world - Wicked Local Dedham - February 23rd, 2020 [February 23rd, 2020]
- THE ADDICTED GARDENER: Environmental tidbits from around the world - Wicked Local Wareham - March 22nd, 2020 [March 22nd, 2020]
- 'Little Foot' skull reveals how this more than 3 million year old human ancestor lived - HeritageDaily - March 22nd, 2020 [March 22nd, 2020]
- It's Not Only About Neurons - The Good Men Project - March 22nd, 2020 [March 22nd, 2020]
- Who is Sir Patrick Vallance and what is his role in government during coronavirus outbreak? - The Scottish Sun - March 22nd, 2020 [March 22nd, 2020]
- University of Washington Pathology Professor Dies of COVID-19 - The Scientist - March 22nd, 2020 [March 22nd, 2020]
- THE ADDICTED GARDENER: Environmental tidbits from around the world - Wicked Local Rochester - March 23rd, 2020 [March 23rd, 2020]
- Ancient human ancestor 'Little Foot' probably lived in trees, new research finds - WBAP News/Talk - March 23rd, 2020 [March 23rd, 2020]
- Study shows similarity in anti-VEGF injection intervals for wet AMD - Ophthalmology Times - March 25th, 2020 [March 25th, 2020]
- aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Announce Government Grant to Fund Bispecific Antibody Development Platform - BioSpace - March 25th, 2020 [March 25th, 2020]
- Health researchers find solution to life-threatening side effect - Mirage News - March 25th, 2020 [March 25th, 2020]
- European Vascular Biology Organisation | Advancing human ... - March 25th, 2020 [March 25th, 2020]
- Vascular Biology Program | Boston Children's Hospital - March 25th, 2020 [March 25th, 2020]
- Vascular Biology Research Program | Johns Hopkins ... - March 25th, 2020 [March 25th, 2020]
- Anatomy of a heatwave: how Antarctica recorded a 20.75C day last month - The Conversation AU - April 1st, 2020 [April 1st, 2020]
- Who is Sir Patrick Vallance and is he speaking at todays government coronavirus press briefing? - The Sun - April 1st, 2020 [April 1st, 2020]